Skip to search formSkip to main contentSkip to account menu

CNOP Regimen

Known as: Cytoxan-Novantrone-Oncovin-Prednisone Regimen 
A regimen consisting of cyclophosphamide, mitoxantrone, vincristine and prednisone used to treat both indolent and aggressive forms of non-Hodgkin's… 
National Institutes of Health

Related topics

Related topics

5 relations
CyclophosphamideLymphoma, Non-HodgkinMitoxantrone HydrochloridePrednisone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Mitoxantrone as a first-line treatment of advanced breast cancer
SummaryForty-two women with measurable or evaluable advanced breast cancer who had received neither prior chemotherapy for… 
2004
2004
Mitoxantrone in the treatment of relapsed and refractory acute leukemia
SummaryTwenty-four patients with acute leukemia or blast crisis (BC) of chronic myelocytic leukemia (CML) in relapse or… 
2004
2004
Mitoxantrone in refractory acute leukemia in children: A phase I study
SummaryNine children with acute non-lymphocytic leukemia (ANLL), ages 16 months to 16 years (median 7 years), and 15 children… 
2004
2004
Sequential studies on the role of mitoxantrone in the treatment of acute leukaemia
SummaryMitoxantrone (Novantrone®; 1, 4-dihydroxy-5, 8-bis [[2-[(2-hydroxyethyl) amino]ethyl]amino-] 9, 10 anthracenedione… 
2002
2002
CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience
The purpose of this study was to evaluate the CNOP regimen (cyclophosphamide, mitoxantrone, vincristine, and prednisone… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)